CD19 and neoplasm: No significant changes appeared in tumour uptake during the long‐term monitoring, and on day 7, the uptake of tumour in CD19‐positive tumour and CD19‐negative tumour was 0.39 ± 0.07%ID/g and 0.40 ± 0.10%ID/g, respectively (P > .05).